- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Protein Forest®, a leading developer of state-of-the-art sample fractionation technology and bioinformatics software for protein research, today announced that it has commenced shipments of its new digital ProteomeChip™ (dPC™) protein separation system. The ProteomeChip system fractionates and concentrates proteins or peptides by isoelectric focusing. It provides higher resolution, greater reproducibility, faster analyses, and easier operation than traditional gel-based protein separation techniques.
Also shipping is Protein Forest's Mass Spec Results and Analysis Tool™ (MSRAT™) bioinformatics software. The MSRAT software is designed to help mass spectrometrists, protein chemists, and other researchers interpret the results of experiments that incorporate dPC™ technology.
The first ProteomeChip system and MSRAT software were delivered to the proteomics group at Thermo Fisher Scientific, the leading developer and manufacturer of mass spectrometric systems for proteomics research. Researchers at Thermo Fisher will use the dPC system with their state-of-the-art ion trap, OrbitrapTM, and triple quadrupole mass spectrometer systems on a variety of challenging proteomics research projects.
"We are proud to work with Protein Forest." said Andreas Hühmer, Ph.D., Director of Proteomics at Thermo Fisher Scientific. "We see the dPC as technology that could be a superior alternative to 2D gels, SDS-PAGE, and HPLC-based sample preparation methodologies in many workflows, and improve the quality and quantity of protein research results."
"We are very pleased that Thermo Fisher Scientific will be using our dPC products. We expect Thermo Fisher scientists to validate the multiple benefits of dPC systems and MSRAT software for mass spectrometry-based proteomics research." said Russell Garlick, Ph.D., President and CEO of Protein Forest.
About Protein Forest, Inc.
Protein Forest, Inc., a privately held company located in Lexington, Massachusetts, is a leading developer and manufacturer of state-of-the-art sample fractionation technology and bioinformatics software for mass spectrometry. The company develops, manufactures, and markets instruments, consumables, and bioinformatics software products for scientists in the life science, drug discovery, pharmaceutical, biotech, and diagnostic industries around the world.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, enabling customers to make the world healthier, cleaner and safer. With annual revenues of $10 billion, the company has more than 30,000 employees and serves over 350,000 customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as environmental and industrial process control settings. Serving customers through two premier brands, Thermo Scientific and Fisher Scientific, the company helps solve analytical challenges from routine testing to complex research and discovery. Thermo Scientific offers customers a complete range of high-end analytical instruments as well as laboratory equipment, software, services, consumables and reagents to enable integrated laboratory workflow solutions. Fisher Scientific provides a complete portfolio of laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety and education. Together, the company offers the most convenient purchasing options to customers and continuously advances its technologies to accelerate the pace of scientific discovery, enhance value for customers and fuel growth for shareholders and employees alike. Visit www.thermofisher.com.
For more information, please click here
Protein Forest, Inc.
128 Spring St.
Lexington, MA 02421
Copyright © Protein Forest, Inc.If you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
Graphene under pressure August 26th, 2016
Graphene under pressure August 26th, 2016
50 years after the release of the film 'Fantastic Voyage,' science upstages fiction: Science upstages fiction with nanorobotic agents designed to travel in the human body to treat cancer August 25th, 2016
University of Puerto Rico and NASA back in the news – XEI reports August 23rd, 2016
Spider silk: Mother Nature's bio-superlens August 22nd, 2016
Thomas Swan and NGI announce unique partnership July 28th, 2016